WASHINGTON (dpa-AFX) - Below are the earnings highlights for Biomarin Pharmaceutical Inc. (BMRN):
-Earnings: $12.9 million in Q2 vs. -$29.2 million in the same period last year. -EPS: $0.07 in Q2 vs. -$0.16 in the same period last year. -Analysts projected -$0.11 per share -Revenue: $501.7 million in Q2 vs. $429.5 million in the same period last year.
Copyright RTT News/dpa-AFX